1. 1000TiPOPINION: A single-arm, open-label, phase IIIb study of olaparib maintenance monotherapy in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) and without germline BRCA mutations (non-gBRCAm). (23rd October 2018) Authors: Poveda, A M; Davidson, R; Blakeley, C; Milner, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1003TiPNeoadjuvant chemotherapy and radical surgery versus chemorradiation for stage IB2, IIA2 e IIB cervical cancer: A randomized controlled trial. (23rd October 2018) Authors: Reis Filho, P T F; Andrade, J M; Batista, M P; Sousa, C B; Oliveira, T H G F; Arruda, G V; Oliveira, T M G; Gabrielli, F; Genta, M L N D; Poveda, A M; Estevez Diz, M D P; Candido Dos Reis, F J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗